Lv11
77 积分 2025-03-06 加入
Targeting B Cells and Plasma Cells in Glomerular Disease
9小时前
待确认
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
2个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
3个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3个月前
已完结
Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes
4个月前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
6个月前
已完结
皖公网安备34019202002308
